awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39263260-A3E2DC93-B1FC-4167-9E0A-71305E573D4B
Q39263260-A3E2DC93-B1FC-4167-9E0A-71305E573D4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39263260-A3E2DC93-B1FC-4167-9E0A-71305E573D4B
Prediction of therapy response in ovarian cancer: Where are we now?
P2860
Q39263260-A3E2DC93-B1FC-4167-9E0A-71305E573D4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39263260-A3E2DC93-B1FC-4167-9E0A-71305E573D4B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3a478c80ca852e57cad9de9f701945627b9594a
P2860
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.